demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID 19 outpatients
fluvoxamine ACTIV-6 Lenze ... COVID-OUT ... TOGETHER

0 studies excluded by filtering options 0